On the other hand, the characterization of immunological profile performed on both cut-offs (1:80 and ≥ 1:160) showed a statistically increase of ANA positivity in MDS patients compared to the NHP and HD control groups. Here, BTG3 is linked to myelodysplastic syndrome.